Podcast Episodes
Back to Search
Episode 89: The Uromigos Paper of the Month - Pembrolizumab in clear cell and non-clear cell renal cancer
Season 1 Episode 89
David McDermott describes these back to back JCO publications.
5 years, 7 months ago
Episode 88: Career Development in Academic Oncology Part 3 - Walter Stadler
Season 1 Episode 88
In these podcasts, we explore academic career development with individuals in different stages of their career.
5 years, 8 months ago
Episode 87: Career Development in Academic Oncology Part 2 - Monty Pal
Season 1 Episode 87
In these podcasts, we explore academic career development with individuals at different stages in their career.
5 years, 8 months ago
Episode 86: Career Development in Academic Oncology Part 1 - Moshe Ornstein
Season 1 Episode 86
In these podcasts, we explore academic career development with individuals in different stages of their career.
5 years, 8 months ago
Episode 85: The CLEAR Trial
Season 1 Episode 85
Toni Choueiri discusses the phase three results
5 years, 8 months ago
Episode 84: Prostate cancer highlights from ASCO #GU21 with Chris Sweeney
Season 1 Episode 84
Chris explores the prostate cancer programme.
5 years, 8 months ago
Episode 83: Is cabozantinib the new standard of care in papillary renal cancer?
Season 1 Episode 83
Monty Pal discusses his randomised phase 2 study in papillary renal cancer.
5 years, 8 months ago
Episode 82: Which is the best VEGF/immune combination for first line metastatic renal cancer?
Season 1 Episode 82
Eric Jonash gives a thoughtful answer to this issue.
5 years, 8 months ago
Episode 81: Noah Hahn discusses front line cisplatin-ineligible PD-L1 data from 361 and 130
Season 1 Episode 81
These new data are important as it is the setting where these agents are currently recommended, but we have not seen the data in this specific subset…
5 years, 8 months ago
Episode 80: Results for Darolutamide in non-metastatic CRPC - the Aramis trial
Season 1 Episode 80
Neil Shore presents the impressive updates for the results of this trial.
5 years, 8 months ago